Evaluating the Glycemic Effects of Dolutegravir and Its Predictors Among People With Human Immunodeficiency Virus in Uganda: A Prospective Cohort Study
Our study showed an increased incidence of hyperglycemia with age, study site, and duration of DTG exposure in people with HIV on TLD. We suggest integrated screening and care for hyperglycemia and diabetes in HIV services, especially when initiating DTG regimens.
Authors
- Barbara Mukasa (ORCID: https://orcid.org/0000-0001-6825-5024)
- Diana Nakitto Kesi (ORCID: https://orcid.org/0000-0002-3989-6794)
- Collins Ankunda (ORCID: https://orcid.org/0000-0003-2130-4014)
- Helen Byomire Ndagije (ORCID: https://orcid.org/0000-0001-5802-4791)
- Susan Nakubulwa
- Yvonne Karamagi (ORCID: https://orcid.org/0009-0004-5566-2455)
- Ivan Mubangizi (ORCID: https://orcid.org/0000-0003-0700-7283)
- Ivan Kasamba (ORCID: https://orcid.org/0000-0001-8175-7301)
- Victoria Prudence Nambasa (ORCID: https://orcid.org/0000-0002-7961-9687)
- Mary Odiit (ORCID: https://orcid.org/0000-0002-0611-5867)
- Curthbert Agolor
- Sharon Namasambi (ORCID: https://orcid.org/0009-0005-6480-6753)
- Jude Emunyu
- Patience Kukundakwe
- Semei Mukama Christopher
Institutions
- Kampala Capital City Authority (UG)
- Mildmay Uganda (UG)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1093/ofid/ofae596
- Citations
- 4
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.76
Funders
- OPEC Fund for International Development